img

Global Microneedles for Trans & Intradermal Drug Delivery Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Medical Devices & Consumables

Publisher : GRD Survey | Format : PDF

Global Microneedles for Trans & Intradermal Drug Delivery Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Microneedles for Trans & Intradermal Drug Delivery market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Microneedles for Trans & Intradermal Drug Delivery market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Microneedles for Trans & Intradermal Drug Delivery in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Solid Microneedles
Hollow Microneedles
Dissolvable Microneedles

Market Snapshot, By Application
Drugs
Vaccines
Proteins
Peptides
Others

Main Market Players Analyzed in this report, including
Zosano Pharma
Valeritas, Inc.
Radius Health
Nanopass Technologies
Dr. Prausnitz Group
Corium International
Clearside Biomedical
Circassia
Becton Dickinson
BD Medical

The study objectives of this report are
To study and analyze the global Microneedles for Trans & Intradermal Drug Delivery market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Microneedles for Trans & Intradermal Drug Delivery market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Microneedles for Trans & Intradermal Drug Delivery manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Microneedles for Trans & Intradermal Drug Delivery market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Microneedles for Trans & Intradermal Drug Delivery submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Microneedles for Trans & Intradermal Drug Delivery are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Microneedles for Trans & Intradermal Drug Delivery Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Microneedles for Trans & Intradermal Drug Delivery Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Microneedles for Trans & Intradermal Drug Delivery

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Microneedles for Trans & Intradermal Drug Delivery Sales Channel and Distributors Analysis
3.3.1 Microneedles for Trans & Intradermal Drug Delivery Sales Channel
3.3.2 Microneedles for Trans & Intradermal Drug Delivery Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Drugs
3.4.2 Major Buyers in Vaccines
3.5 Microneedles for Trans & Intradermal Drug Delivery Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Microneedles for Trans & Intradermal Drug Delivery Type Introduction
4.1.1 Solid Microneedles
4.1.2 Hollow Microneedles
4.1.3 Dissolvable Microneedles
4.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Type 2016-2021
4.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Type 2016-2021
4.4 Global Microneedles for Trans & Intradermal Drug Delivery Price by Type 2016-2021

5 Market Segment: by Application
5.1 Microneedles for Trans & Intradermal Drug Delivery Type Introduction
5.1.1 Drugs
5.1.2 Vaccines
5.1.3 Proteins
5.1.3 Peptides
5.1.4 Others
5.2 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Application 2016-2021
5.3 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Application 2016-2021
5.4 Global Microneedles for Trans & Intradermal Drug Delivery Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Microneedles for Trans & Intradermal Drug Delivery Market by Region
6.1.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales by Regions
6.1.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue by Regions
6.2 North America Microneedles for Trans & Intradermal Drug Delivery Market 2016-2021
6.3 Europe Microneedles for Trans & Intradermal Drug Delivery Market 2016-2021
6.4 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market 2016-2021
6.5 South America Microneedles for Trans & Intradermal Drug Delivery Market 2016-2021
6.6 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market 2016-2021

7 North America
7.1 North America Microneedles for Trans & Intradermal Drug Delivery Market by Country 2016-2021
7.1.1 North America Microneedles for Trans & Intradermal Drug Delivery Sales by Country
7.1.2 North America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Microneedles for Trans & Intradermal Drug Delivery Market by Country 2016-2021
8.1.1 Europe Microneedles for Trans & Intradermal Drug Delivery Sales by Country
8.1.2 Europe Microneedles for Trans & Intradermal Drug Delivery Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Market by Country 2016-2021
9.1.1 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales by Country
9.1.2 Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Microneedles for Trans & Intradermal Drug Delivery Market by Country 2016-2021
10.1.1 South America Microneedles for Trans & Intradermal Drug Delivery Sales by Country
10.1.2 South America Microneedles for Trans & Intradermal Drug Delivery Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Market by Country 2016-2021
11.1.1 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales by Country
11.1.2 Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Zosano Pharma
12.1.1 Zosano Pharma Company Information
12.1.2 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
12.1.3 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Zosano Pharma Key Development
12.2 Valeritas, Inc.
12.2.1 Valeritas, Inc. Company Information
12.2.2 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
12.2.3 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Valeritas, Inc. Key Development
12.3 Radius Health
12.3.1 Radius Health Company Information
12.3.2 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
12.3.3 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Radius Health Key Development
12.4 Nanopass Technologies
12.4.1 Nanopass Technologies Company Information
12.4.2 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
12.4.3 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Nanopass Technologies Key Development
12.5 Dr. Prausnitz Group
12.5.1 Dr. Prausnitz Group Company Information
12.5.2 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
12.5.3 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Dr. Prausnitz Group Key Development
12.6 Corium International
12.6.1 Corium International Company Information
12.6.2 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
12.6.3 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Corium International Key Development
12.7 Clearside Biomedical
12.7.1 Clearside Biomedical Company Information
12.7.2 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
12.7.3 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Corium International Key Development
12.9 Becton Dickinson
12.9.1 Becton Dickinson Company Information
12.9.2 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
12.9.3 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Becton Dickinson Key Development
12.8 Circassia
12.8.1 Circassia Company Information
12.8.2 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
12.8.3 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Circassia Key Development

13 Global Microneedles for Trans & Intradermal Drug Delivery Market Forecast by Region by Type and by Application
13.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales, Revenue Forecast 2022-2027
13.2 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Regions
13.2.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Region 2022-2027
13.2.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Region 2022-2027
13.3 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Type
13.3.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Type 2022-2027
13.3.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Type 2022-2027
13.3.3 Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Type 2022-2027
13.4 Global Microneedles for Trans & Intradermal Drug Delivery Forecast by Application
13.4.1 Global Microneedles for Trans & Intradermal Drug Delivery Sales Forecast by Application 2022-2027
13.4.2 Global Microneedles for Trans & Intradermal Drug Delivery Revenue Forecast by Application 2022-2027
13.4.3 Global Microneedles for Trans & Intradermal Drug Delivery Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Microneedles for Trans & Intradermal Drug Delivery Production Specifications
Table 2: Drivers in Microneedles for Trans & Intradermal Drug Delivery Market
Table 3: Restraints Microneedles for Trans & Intradermal Drug Delivery Market
Table 4: Opportunity in Microneedles for Trans & Intradermal Drug Delivery Market
Table 5: Comparion of Alternative and Microneedles for Trans & Intradermal Drug Delivery
Table 6: Microneedles for Trans & Intradermal Drug Delivery Raw Materials Key Suppliers List
Table 7: Microneedles for Trans & Intradermal Drug Delivery Distributors List
Table 8: Microneedles for Trans & Intradermal Drug Delivery Major Buyers in Drugs
Table 9: Microneedles for Trans & Intradermal Drug Delivery Major Buyers in Vaccines
Table 10: Microneedles for Trans & Intradermal Drug Delivery Major Buyers in Proteins
Table 11: Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Type 2016-2021
Table 12: Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type 2016-2021
Table 13: Global Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) by Type 2016-2021
Table 14: Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type 2016-2021
Table 15: Global Microneedles for Trans & Intradermal Drug Delivery Price by Type 2016-2021
Table 16: Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Application 2016-2021
Table 17: Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application 2016-2021
Table 18: Global Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) by Application 2016-2021
Table 19: Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application 2016-2021
Table 20: Global Microneedles for Trans & Intradermal Drug Delivery Price by Application 2016-2021
Table 21: Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Region 2016-2021
Table 22: Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region 2016-2021
Table 23: Global Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) by Region 2016-2021
Table 24: Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region 2016-2021
Table 25: North America Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Country 2016-2021
Table 26: North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country 2016-2021
Table 27: North America Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) by Country 2016-2021
Table 28: North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country 2016-2021)
Table 29: Europe Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Country 2016-2021
Table 30: Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country 2016-2021
Table 31: Europe Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) by Country 2016-2021
Table 32: Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country 2016-2021)
Table 37: South America Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Country 2016-2021
Table 38: South America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country 2016-2021
Table 39: South America Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) by Country 2016-2021
Table 40: South America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country 2016-2021)
Table 45 Zosano Pharma Company Information
Table 46 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
Table 47 Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Valeritas, Inc. Company Information
Table 49 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
Table 50 Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Radius Health Company Information
Table 52 Radius Health Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
Table 53 Radius Health Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Nanopass Technologies Company Information
Table 55 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
Table 56 Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Dr. Prausnitz Group Company Information
Table 58 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
Table 59 Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Corium International Company Information
Table 61 Corium International Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
Table 62 Corium International Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Clearside Biomedical Company Information
Table 64 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
Table 65 Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Circassia Company Information
Table 67 Circassia Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
Table 68 Circassia Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Becton Dickinson Company Information
Table 70 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Product Portfolio, Specification and Application
Table 71 Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Microneedles for Trans & Intradermal Drug Delivery Picture
Figure 2: Global Microneedles for Trans & Intradermal Drug Delivery Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Microneedles for Trans & Intradermal Drug Delivery Supply Chain Analysis
Figure 5: Microneedles for Trans & Intradermal Drug Delivery Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Solid Microneedles
Figure 7: Product Picture of Hollow Microneedles
Figure 8: Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Type, 2020
Figure 9: Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Type, 2020
Figure 10: Microneedles for Trans & Intradermal Drug Delivery in Drugs
Figure 11: Global Microneedles for Trans & Intradermal Drug Delivery Market: Drugs 2016-2021
Figure 12: Microneedles for Trans & Intradermal Drug Delivery in Vaccines
Figure 13: Global Microneedles for Trans & Intradermal Drug Delivery Market: Vaccines 2016-2021
Figure 14: Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Application, 2020
Figure 15: Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Application, 2020
Figure 16: Global Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Region 2016-2021
Figure 17: Global Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Region 2016-2021
Figure 18: North America Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 19: North America Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 20: Europe Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 21: Europe Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 24: South America Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 25: South America Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 28: North America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country, 2020
Figure 29: North America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country, 2020
Figure 30: United States Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 31: United States Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 32: Canada Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 33: Canada Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 35: Mexico Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 36: Europe Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country, 2020
Figure 37: Europe Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country, 2020
Figure 38: Germany Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 39: Germany Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 40: France Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 41: France Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 42: UK Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 43: UK Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 44: Italy Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 45: Italy Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 46: Russia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 46: Russia Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 47: Spain Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 48: Spain Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country, 2020
Figure 50: Asia Pacific Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country, 2020
Figure 51: China Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 52: China Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 53: Japan Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 54: Japan Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 55: Korea Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 56: Korea Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 59: India Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 60: India Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 61: Australia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 62: Australia Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 63: South America Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country, 2020
Figure 64: South America Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country, 2020
Figure 65: Brazil Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 66: Brazil Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 68: Argentina Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 70: Colombia Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share by Country, 2020
Figure 73: Turkey Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 74: Turkey Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Status 2016-2021
Figure 78: South Africa Microneedles for Trans & Intradermal Drug Delivery Revenue (Million USD) Status 2016-2021
Figure 79: Zosano Pharma Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 80: Valeritas, Inc. Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 81: Radius Health Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 82: Nanopass Technologies Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 83: Dr. Prausnitz Group Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 84: Corium International Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 85: Clearside Biomedical Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 86: Circassia Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 87: Becton Dickinson Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 88: BD Medical Microneedles for Trans & Intradermal Drug Delivery Revenue Market Share Globally (2019-2021)
Figure 89: Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Forecast (2022-2027)
Figure 90: Global Microneedles for Trans & Intradermal Drug Delivery Sales (K Units) Forecast (2022-2027)